Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Medical Device
Hotgen Biotech Receives UK Approvals for Monkeypox and COVID-19 Antigen Detection Kits
February 10, 2025
Company
Drug
Zelgen Biopharm’s Donafenib Shows Promise in Phase III Study for RAIR-DTC
February 10, 2025
R&D
BGI’s Stereo-seq Tech Maps Axolotl Brain Regeneration in World-First Study
February 10, 2025
Company
Drug
Yingli Pharma Doses First Patient in Linperlisib Phase II Trial for PTCL
February 10, 2025
Company
Deals
Junshi Biosciences Plans USD 572M Private Placement to Fund Drug R&D and Expansion
February 10, 2025
Company
Drug
CanSino, Livzon Win China EUAs for COVID-19 Booster Vaccines
February 10, 2025
Company
Deals
AWS Partners with Zhongshan to Launch Smart Manufacturing and Biomedical Digital Center
February 10, 2025
Company
Deals
BoomRay Pharmaceuticals Raises USD 43M in Series A for RDC Pipeline Expansion
February 10, 2025
Company
Drug
Zelgen Biopharmaceuticals’ Jacktinib Wins FDA Approval for Severe Alopecia Areata
February 10, 2025
Company
Drug
Jacobio Pharmaceuticals Doses First Patient in JAB-BX102 Phase I/IIa Trial for CD73-Targeted Cancer Therapy
February 10, 2025
Company
Deals
Northeast Pharma Licenses MedAbome’s MAb11-22.1 for ADC and CAR-T Development
February 10, 2025
Company
Drug
Alphamab Oncology Highlights KN046, KN026 Advances at ESMO 2022
February 10, 2025
1
2
…
15
16
17
18
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?